ERIN CRANE: Open Payments
NPI 1861165441 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,705 in 144 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $1,578 · 2025 $2,705
Food & beverage: $2,705
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 76 | $1,288 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $249 |
| Ardelyx, Inc. | 10 | $146 |
| Novo Nordisk Inc | 1 | $113 |
| Regeneron Healthcare Solutions, Inc. | 4 | $96 |
| Aimmune Therapeutics, Inc. | 4 | $94 |
| Madrigal Pharmaceuticals | 5 | $92 |
| Phathom Pharmaceuticals, Inc. | 7 | $84 |
| GENZYME CORPORATION | 2 | $81 |
| Daiichi Sankyo Inc. | 4 | $79 |
Products named: RINVOQ, LINZESS, DUPIXENT, SKYRIZI, IBSRELA, CREON, ENTYVIO, EOHILIA.
Industry payments across OH — which companies pay providers there.
